Subsequent validation confirmed that serum PTX3 levels are significantly elevated in lung cancer patients compared to healthy individuals (83), but still lower than in patients with chronic obstructive pulmonary disease (COPD) (84). This evidence concerns the gene PTX3 and chronic obstructive pulmonary disease.